neutrophil lymphocyte ratio
Selected indexed studies
- Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: A meta-analysis. (Am J Emerg Med, 2020) [PMID:31785981]
- Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. (J Natl Cancer Inst, 2014) [PMID:24875653]
- The association of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and lymphocyte to monocyte ratio with post-thrombolysis early neurological outcomes in patients with acute ischemic stroke. (J Neuroinflammation, 2021) [PMID:33610168]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: an update. (2016) pubmed
- Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: A meta-analysis. (2020) pubmed
- Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. (2014) pubmed
- The association of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and lymphocyte to monocyte ratio with post-thrombolysis early neurological outcomes in patients with acute ischemic stroke. (2021) pubmed
- The neutrophil-to-lymphocyte ratio in cutaneous oncology: Simply elegant. (2022) pubmed
- Prognostic role of neutrophil-to-lymphocyte ratio to laryngeal squamous cell carcinoma: a meta-analysis. (2022) pubmed
- Neutrophil Lymphocyte Ratio as a Prognostic Marker in Acute Ischemic Stroke: a Systematic Review and Meta-analysis. (2021) pubmed
- Neutrophil-to-lymphocyte ratio as a predictive biomarker for hyperprogressive disease mediated by immune checkpoint inhibitors: a systematic review and meta-analysis. (2024) pubmed
- Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck squamous cell carcinoma treated with immune checkpoint inhibitors: Meta-analysis. (2022) pubmed
- Neutrophil to lymphocyte ratio predicts poor outcomes after acute ischemic stroke: A cohort study and systematic review. (2019) pubmed